COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Chen, Yu-Wei, Tucker, Matthew D., Beckermann, Kathryn E., Iams, Wade T., Rini, Brian I., Johnson, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316066/
https://www.ncbi.nlm.nih.gov/pubmed/34400057
http://dx.doi.org/10.1016/j.ejca.2021.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316066/
https://www.ncbi.nlm.nih.gov/pubmed/34400057
http://dx.doi.org/10.1016/j.ejca.2021.07.017

Ejemplares similares